Enova International, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Enova International, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.15B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $2.66B | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $2.12B | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $1.74B | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $1.21B | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $1.08B | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | $345.26M | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $305.61M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $259.45M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $264.44M | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $308.39M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $209.45M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $175.12M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $207.42M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $256.30M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $377.84M | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | ($50.55M) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | $27.09M | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | $25.06M | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | $35.02M | Feb 27, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $739.43M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $584.76M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $422.14M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $383.99M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $413.06M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $357.80M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $248.21M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $175.55M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $116.19M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $121.48M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.47B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $5.27B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $4.59B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $3.78B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $2.76B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $2.11B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.57B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.33B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.16B | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $977.88M | Feb 26, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.13B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $4.07B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $3.35B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.59B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.67B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $1.19B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $1.20B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $986.58M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $877.77M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $736.18M | Feb 26, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.34B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $1.20B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $1.24B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $1.19B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.09B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $917.35M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $376.61M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $347.77M | Feb 27, 2020 |
| FY2019 | Dec 31, 2017 | $281.69M | Feb 27, 2020 |
| FY2019 | Dec 31, 2016 | $241.70M | Feb 27, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 11 | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 27, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11 | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | 7 | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | 6 | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | 6 | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | 11 | Feb 24, 2023 |
| FY2019 | Dec 31, 2019 | (1) | Feb 27, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 27, 2020 |
| FY2019 | Mar 31, 2019 | 1 | Feb 27, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $71.71M | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $73.91M | Feb 20, 2026 |
| FY2025 | Dec 31, 2023 | $54.36M | Feb 20, 2026 |
| FY2024 | Dec 31, 2022 | $100.17M | Feb 18, 2025 |
| FY2023 | Dec 31, 2021 | $165.48M | Feb 23, 2024 |
| FY2022 | Dec 31, 2020 | $297.27M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $35.90M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $28.11M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $49.77M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $39.93M | Feb 27, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.50B | Feb 20, 2026 |
| FY2025 | Dec 31, 2024 | $3.56B | Feb 20, 2026 |
| FY2024 | Dec 31, 2023 | $2.94B | Feb 18, 2025 |
| FY2023 | Dec 31, 2022 | $2.26B | Feb 23, 2024 |
| FY2022 | Dec 31, 2021 | $1.38B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $946.46M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $991.18M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $857.93M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $788.54M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $649.91M | Feb 26, 2018 |